Antithrombotic potential of dihomo-gamma-linolenic acid in man.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMC 1632618)

Published in Br Med J on December 03, 1977

Authors

P B Kernoff, A L Willis, K J Stone, J A Davies, G P McNicol

Articles by these authors

(truncated to the top 100)

Aspirin selectively inhibits prostaglandin production in human platelets. Nat New Biol (1971) 7.75

The characterization of ficaprenol-10, -11 and 12 from the leaves of Ficus elastica (decorative rubber plant). Biochem J (1967) 3.95

Parallel assay of prostaglandin-like activity in rat inflammatory exudate by means of cascade superfusion. J Pharm Pharmacol (1969) 3.59

The 'subcortical dementia' of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry (1974) 3.48

Serial CD4 lymphocyte counts and development of AIDS. Lancet (1991) 3.42

The stereochemistry of hexahydroprenol, ubiquinone and ergosterol biosynthesis in the mycelium of Aspergillus fumigatus Fresenius. Biochem J (1967) 2.75

Mechanism of action of bacitracin: complexation with metal ion and C 55 -isoprenyl pyrophosphate. Proc Natl Acad Sci U S A (1971) 2.42

Cutaneous reactions to intradermal prostaglandins. Br J Pharmacol (1971) 2.27

Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis. Clin Exp Immunol (1992) 2.27

Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet (1989) 2.23

Randomised trial of oral aspirin for chronic venous leg ulcers. Lancet (1994) 2.20

Cellular responses of Bacillus subtilis and Escherichia coli to the Gram stain. J Bacteriol (1983) 2.16

Isolation of Chlamydia trachomatis from Bartholin's ducts. Br J Vener Dis (1978) 2.13

An enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin. Science (1974) 2.08

Lack of evidence for abnormal fibrinolysis in chronic low back pain. Br J Rheumatol (1993) 2.02

An endoperoxide aggregator (Lass), formed in platelets in response to thrombotic stimuli: purification, identification and unique biological significance. Prostaglandins (1974) 2.02

Fibrin degradation products in normal and abnormal pregnancy and parturition. Br Med J (1969) 1.92

Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ (1992) 1.86

Idiopathic gangrene in African children. Br Med J (1967) 1.85

Characterization of the hexahydropolyprenols of Aspergillus fumigatus Fresenius. Biochem J (1967) 1.85

The natural history of human immunodeficiency virus infection in a haemophilic cohort. Br J Haematol (1989) 1.84

Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J Med Chem (1995) 1.83

Carbohydrate fermentation patterns of Neisseria meningitidis determined by a microtiter method. Appl Microbiol (1971) 1.71

Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders. Gut (1981) 1.67

Effects of physiological concentrations of vasopressin on haemostatic function in man. Clin Sci (Lond) (1985) 1.64

Fibrinolytic enzyme system and pregnancy. Br Med J (1969) 1.63

The effect of rifampin on the nasopharyngeal carriage of Neisseria meningitidis in a military population. J Infect Dis (1971) 1.63

Coronavirus infections in military recruits. Three-year study with coronavirus strains OC43 and 229E. Am Rev Respir Dis (1974) 1.62

Formation and release of prostaglandins by platelets in response to thrombin. Br J Pharmacol (1970) 1.59

Preoperative prediction of postoperative deep vein thrombosis. Br Med J (1976) 1.58

Erk MAP kinase regulates branching morphogenesis in the developing mouse kidney. Development (2001) 1.57

Isolation of a chemical trigger for thrombosis. Prostaglandins (1974) 1.57

Fibrinolytic enhancement by stanozolol: a double blind trial. Br J Haematol (1972) 1.53

Molecular and cytogenetic analysis of the heterochromatin-euchromatin junction region of the Drosophila melanogaster X chromosome using cloned DNA sequences. Genetics (1990) 1.51

Quantitative aspects of chlamydial infection of the cervix. Br J Vener Dis (1980) 1.51

The frequency of dental attendance of Scottish dentate adults between 1978 and 1988. Br Dent J (1991) 1.47

Interaction between prostaglandins E and F given intradermally in the rat. Br J Pharmacol (1971) 1.47

Activation of the ppp(A2'p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2'p)nA-dependent RNase. Eur J Biochem (1984) 1.45

Drosophila Shaking-B protein forms gap junctions in paired Xenopus oocytes. Nature (1998) 1.44

The relation of pyrexia and nasal inflammatory response to virus levels in nasal washings of ferrets infected with influenza viruses of differing virulence. Br J Exp Pathol (1977) 1.43

Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity. Lancet (1970) 1.42

Report on an epidemic due to Shigella dysenteriae, type 1, in the Somali interior. Am J Trop Med Hyg (1966) 1.41

Coagulation and fibrinolytic systems in pre-eclampsia and eclampsia. Br Med J (1971) 1.39

Mutations in shaking-B prevent electrical synapse formation in the Drosophila giant fiber system. J Neurosci (1996) 1.38

Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy. Thromb Haemost (1989) 1.37

Innexins: a family of invertebrate gap-junction proteins. Trends Genet (1998) 1.36

Non-usefulness of meningococcal carriage-rates. Lancet (1973) 1.35

A rather sad document. Br Med J (1979) 1.35

Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonay embolism. Br Med J (1974) 1.35

Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron (1998) 1.34

A variant of factor 8 related antigen. Br J Haematol (1974) 1.31

Microangiopathic haemolytic anaemia and the pathogenesis of malignant hypertension. Lancet (1969) 1.31

Coagulation, fibrinolysis and platelet function in pre-eclampsia, essential hypertension and placental insufficiency. J Obstet Gynaecol Br Commonw (1971) 1.29

Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease. Br J Haematol (1982) 1.28

Prediction of progression to AIDS by analysis of CD4 lymphocyte counts in a haemophilic cohort. AIDS (1989) 1.27

More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell counts. J Acquir Immune Defic Syndr (1991) 1.26

Haemostatic changes during dialysis associated with thrombus formation on dialysis membranes. Br Med J (1972) 1.24

Simplified thin-layer chromatography of prostaglanding in biological extracts. Br J Pharmacol (1970) 1.24

Coagulation and fibrinolytic mechanisms during and after normal childbirth. Br Med J (1970) 1.21

The use of different lipids to express serum tocopherol: lipid ratios for the measurement of vitamin E status. Ann Clin Biochem (1986) 1.20

Symptomless HIV infection after more than ten years. Lancet (1990) 1.18

Chemical mechanism of the Gram stain and synthesis of a new electron-opaque marker for electron microscopy which replaces the iodine mordant of the stain. J Bacteriol (1983) 1.18

A new potential mediator of arterial thrombosis whose biosynthesis is inhibited by aspirin. Prostaglandins (1973) 1.17

Null mutation in shaking-B eliminates electrical, but not chemical, synapses in the Drosophila giant fiber system: a structural study. J Comp Neurol (1999) 1.17

A congenital defect in platelet prostaglandin production associated with impaired hemostasis in storage pool disease. Prostaglandins (1973) 1.17

Dihomo-gamma-linolenate suppresses platelet aggregation when administered in vitro or in vivo. Prostaglandins (1974) 1.16

Inhibition of intestinal tone and prostaglandin synthesis by 5,8,11,14 tetraynoic acid. Br J Pharmacol (1972) 1.16

High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin. Br J Haematol (1985) 1.15

The effects of therapy with oestriol succinate and ethinyl oestradiol on the haemostatic mechanism in post-menopausal women. Thromb Haemost (1976) 1.14

Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. Heart (1997) 1.13

Field trial of an inactivated Mycoplasma pneumoniae vaccine. I. Vaccine efficacy. J Infect Dis (1976) 1.12

Proceedings: Thrombolytic and anti-thrombotic properties of dihomo-gamma-linolenate in vitro. Br J Pharmacol (1975) 1.11

Association of fibrinogen-fibrin-related antigen (F.R.-antigen) with postoperative deep-vein thrombosis and systemic complications. Lancet (1972) 1.11

Calcium/NFAT signalling promotes early nephrogenesis. Dev Biol (2011) 1.10

Severe allergic pulmonary oedema after plasma transfusion. Br J Haematol (1972) 1.09

Contribution of a general practitioner hospital: a further study. BMJ (1990) 1.08

Reactions to low-molecular-weight porcine factor VIII concentrates. Br Med J (Clin Res Ed) (1981) 1.08

Repeated injection of prostaglandin E2 in rat paws induces chronic swelling and a marked decrease in pain threshold. Prostaglandins (1973) 1.08

Outcome of a second pregnancy after a previous elective caesarean section. Br J Obstet Gynaecol (1990) 1.08

Pharmacological emptying of the stomach with metoclopramide. Br Med J (1971) 1.07

Epsilon-Aminocaproic acid therapy for dental extractions in haemophilia and Christmas disease: a double blind controlled trial. Br J Haematol (1971) 1.07

Two Drosophila innexins are expressed in overlapping domains and cooperate to form gap-junction channels. Mol Biol Cell (2000) 1.07

Plasminogen-activator-producing tumour. Br Med J (1969) 1.07

Hypothyroidism as a cause of acquired von Willebrand's disease. Lancet (1987) 1.07

Selective inhibition of prostaglandin biosynthesis by gold salts and phenylbutazone. Prostaglandins (1975) 1.06

Proceedings: Transfusion and gel filtration studies in von Willebrand's disease. Br J Haematol (1974) 1.05

Quantification of hepatic transcribing RNA polymerase molecules, polyribonucleotide elongation rates and messenger RNA complexity in fed and fasted rats. Eur J Biochem (1978) 1.04

Growth of herpes simplex type 1 on skin explants of atopic eczema. Clin Exp Dermatol (1996) 1.04

Clinical experience with polyelectrolyte-fractionated porcine factor VIII concentrate in the treatment of hemophiliacs with antibodies to factor VIII. Blood (1984) 1.04

Synaptogenesis in the giant-fibre system of Drosophila: interaction of the giant fibre and its major motorneuronal target. Development (2000) 1.04

Angiotensin-converting enzyme insertion/deletion polymorphism and cerebrovascular disease. Stroke (1996) 1.03

Reduction of thrombus formation on dialyser membranes by aspirin and RA 233. Lancet (1972) 1.03

Isolation of polyisoprenyl alcohols from Streptococcus faecalis. J Bacteriol (1972) 1.03

Inheritance and bleeding in factor XI deficiency. Br J Haematol (1988) 1.02

Towards a genetic basis for kidney development. Mech Dev (1994) 1.01

Coagulation and fibrinolytic activity in Behçet's disease. Thromb Haemost (1991) 1.00

Actions and interactions of prostaglandins administered intradermally in rat and in man. Br J Pharmacol (1969) 1.00

Simultaneous loss of expression of syndecan-1 and E-cadherin in the embryonic palate during epithelial-mesenchymal transformation. Int J Dev Biol (1998) 1.00

Haemostatic responses and vasopressin release during colonoscopy in man. Clin Sci (Lond) (1991) 0.99

Plasma fractionation methods and T-cell subsets in haemophilia. Lancet (1983) 0.98